Results 41 to 50 of about 216,446 (286)
The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility. [PDF]
Background: The parameter uncertainty in the six-dimensional health state short form (SF-6D) value sets is commonly ignored. There are two sources of parameter uncertainty: uncertainty around the estimated regression coefficients and uncertainty around the model’s specification.
Kharroubi SA +3 more
europepmc +6 more sources
US valuation of the SF-6D. [PDF]
Background. The original SF-6D valuation study collected 3503 standard gambled responses from 611 UK respondents to predict quality-adjusted life year (QALY) values. Methods. Using 19,980 paired comparison responses from 666 US respondents and a stacked probit model, the 25 coefficients of the original SF-6D multiattribute utility (MAU) regression ...
Craig BM +3 more
europepmc +5 more sources
Exploring the Consistency of the SF-6D [PDF]
The six-dimensional health state short form (SF-6D) was designed to be derived from the short-form 36 health survey (SF-36). The purpose of this research was to compare the SF-6D index values generated from the SF-36 (SF-6DSF-36) with those obtained from the SF-6D administered as an independent instrument (SF-6DInd).
Ferreira, Lara Noronha +4 more
openaire +3 more sources
Unchained melody: revisiting the estimation of SF-6D values. [PDF]
In the original SF-6D valuation study, the analytical design inherited conventions that detrimentally affected its ability to predict values on a quality-adjusted life year (QALY) scale. Our objective is to estimate UK values for SF-6D states using the original data and multi-attribute utility (MAU) regression after addressing its limitations and to ...
Craig BM.
europepmc +4 more sources
The EuroQuality of life-5 dimension 5 level (EQ-5D-5L) and Short Form-6 Dimension (SF-6D) are the most widely used generic instruments for assessing utility as an outcome parameter in pharmacoeconomic studies.
Tri Murti Andayani +3 more
doaj +1 more source
A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). [PDF]
The appropriate use of generic preference-based measures determines the accuracy of disease assessment and further decision on healthcare policy using quality adjusted life years.
Jing Chen +4 more
doaj +1 more source
The Short Form-6 Dimension (SF-6D) Validity and Reliability in Hemodialysis Patients
Background: Quality of life becomes an important parameter that is needed for assessing the clinical outcome of patients undergoing long-term therapy for chronic diseases, such as chronic kidney failure.
Anisa Zulfa Fatihah +2 more
doaj +1 more source
Objectives The current study aimed to map the disease-specific Schizophrenia Quality of Life Scale (SQLS) onto the three- and five-level EuroQol five-dimension (EQ-5D-3 L and EQ-5D-5 L), Health Utility Index Mark 3 (HUI3) and Short Form six-dimensional ...
Lee Seng Esmond Seow +5 more
semanticscholar +1 more source
The estimation of a preference-based measure of health from the SF-36 [PDF]
This paper reports on the findings of a study to derive a preference-based measure of health from the SF-36 for use in economic evaluation. The SF-36 was revised into a six-dimensional health state classification called the SF-6D.
Brazier +13 more
core +1 more source
Analysis of SF-6D Index Data: Is Beta Regression Appropriate? [PDF]
Preference-weighted index scores of health-related quality of life are commonly skewed to the left and bounded at one. Beta regression is used in various disciplines to address the specific features of bounded outcome variables such as heteroscedasticity, but has rarely been used in the context of health-related quality of life measures.
Hunger, Matthias +2 more
openaire +2 more sources

